Table V.
Adverse Events
| Adverse Event, No. (%) | Lisinopril Monotherapy (n=129) | Carvedilol CR Monotherapy (n=130) | Carvedilol CR + Lisinopril Combination Therapy (n=391) | Total (N=650) |
|---|---|---|---|---|
| Headache | 12 (9%) | 16 (12%) | 31 (8%) | 59 (9%) |
| Dizziness | 9 (7%) | 10 (8%) | 27 (7%) | 46 (7%) |
| Cough | 10 (8%) | 1 (<1%) | 27 (7%) | 38 (6%) |
| Fatigue | 5 (4%) | 6 (5%) | 25 (6%) | 36 (6%) |
| Nausea | 5 (4%) | 5 (4%) | 13 (3%) | 23 (4%) |
| Diarrhea | 3 (2%) | 1 (<1%) | 17 (4%) | 21 (3%) |
| Upper respiratory tract infection | 5 (4%) | 0 | 14 (4%) | 19 (3%) |
| Back pain | 1 (<1%) | 4 (3%) | 11 (3%) | 16 (2%) |
| Nasopharyngitis | 2 (2%) | 2 (2%) | 11 (3%) | 15 (2%) |
| Influenza | 1 (<1%) | 0 | 10 (3%) | 11 (2%) |
| Sinus congestion | 1 (<1%) | 2 (2%) | 5 (1%) | 8 (1%) |
| Sinusitis | 0 | 2 (2%) | 5 (1%) | 7 (1%) |
| Myalgia | 3 (2%) | 0 | 4 (1%) | 7 (1%) |
| Dyspnea | 1 (<1%) | 1 (<1%) | 5 (1%) | 7 (1%) |
| Vertigo | 0 | 0 | 3 (<1%) | 3 (<1%) |